Latest news with #minimallyinvasive
Yahoo
7 days ago
- Business
- Yahoo
Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System
CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ('Aurora Spine' or the 'Company') (TSXV: ASG) (OTCQB: ASAPF), a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO™ Sacroiliac (SI) Joint Fusion System has been successfully used in over 2,500 procedures across the United States. This major milestone underscores the company's accelerating growth and increasing adoption of its minimally invasive technology by surgeons nationwide. Aurora's SiLO™ platform, which includes the SiLO-TFX™ system, is engineered to improve outcomes for patients suffering from SI joint pain and dysfunction. Utilizing a posterior approach, the system enables secure transfixation across the SI joint, delivering enhanced fixation, reduced recovery times, and consistently high patient satisfaction. 'This milestone is a key indicator of market acceptance and commercial scalability,' said Trent Northcutt, CEO of Aurora Spine. 'SiLO™ is resonating with surgeons who want smarter solutions, and this is only the beginning. Our commitment to innovation, education, and execution continues to unlock meaningful growth opportunities.' Key Drivers of Growth: 2,500+ SiLO™ Procedures Performed Nationwide Rapid expansion of Aurora's U.S. sales network Launch of targeted surgeon education programs Continued innovation across the minimally invasive spine portfolio The SiLO-TFX™ system has gained traction due to its intuitive instrumentation and reproducible outcomes, as reflected in glowing feedback from the surgical community: 'The SiLO-TFX™ system offers unprecedented clinical advantages in my practice,' said Dr. Michael Stoffman, MD, Neurosurgeon. 'The instrumentation is intuitive, precise, and designed with the surgeon's workflow in mind, allowing for consistent, reproducible outcomes and improved patient recovery.' In addition to the SiLO™ platform, Aurora's growing suite of innovations includes the AERO™ Facet Fusion System and the DEXA TECHNOLOGY™-matched interbody implants—the world's first spinal implants customized to a patient's bone density. 'Our goal is to provide the most effective and least invasive treatment options, supported by robust clinical evidence,' said Matthew Goldstone, Chief Commercial Officer. 'We're proud to have multiple peer-reviewed publications in 2025, with more on the horizon. Clinical data is the key to shaping the future of spine care.' 'Aurora Spine leads in spine innovation with our SiLO™ platform, which has now surpassed 2,500 procedures,' added Laszlo Garamszegi, Chief Technology Officer. 'Positive feedback from surgeons and patients continues to inspire us as we introduce advanced technologies like AERO™ and DEXA-based implants. We're committed to driving the future of minimally invasive spine treatments through design excellence and clinical science.' Aurora Spine remains focused on delivering groundbreaking spinal technologies that empower surgeons, improve patient outcomes, and lead the evolution of minimally invasive spine surgery. About Aurora Spine Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at or Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances. Company Contacts: Aurora Spine Corporation Trent Northcutt President and Chief Executive Officer (760) 424-2004 Chad Clouse Chief Financial Officer (760) 424-2004 Investor Contact: Adam Lowensteiner Lytham Partners (646) 829-9702 Email: asapf@ Sign in to access your portfolio
Associated Press
15-06-2025
- Health
- Associated Press
NovoSculpt Named Best Body Contouring Clinic in the Tri-State Area for 2025
NovoSculpt has been honored as the Best Body Contouring Clinic in the Tri-State Area for 2025, solidifying its place as a leader in aesthetic care and body sculpting services. Greenwich, CT, USA, June 15, 2025 -- NovoSculpt Celebrates Prestigious Recognition in Body Contouring Excellence NovoSculpt proudly announces its recognition as the Best Body Contouring Clinic in the Tri-State Area for 2025, a prestigious title that highlights the clinic's leadership in the rapidly growing field of body sculpting. The award emphasizes NovoSculpt's unwavering commitment to providing safe, effective, and customized solutions for those seeking transformative aesthetic results. The recognition celebrates the clinic's dedication to patient care, innovative treatments, and personalized experiences, solidifying its position as the premier destination for body contouring in the region. NovoSculpt's approach to aesthetic medicine continues to disrupt traditional methods by focusing on minimally invasive treatments that provide lasting and natural results. A Cutting-Edge Approach to Minimally Invasive Fat Removal At the heart of NovoSculpt's success is its groundbreaking minimally invasive fat removal procedure, which allows patients to remove up to 11 pounds of localized fat in a single session. This innovative technique eliminates the need for scalpels, stitches, or general anesthesia, providing a safe and efficient solution for body sculpting. The procedure ensures a quick recovery time, with many patients resuming their daily activities in as little as 24 hours. NovoSculpt's approach has proven to be a highly effective and patient-friendly alternative to traditional body contouring surgeries, enabling clients to achieve their desired body shape with minimal discomfort and downtime. This cutting-edge method continues to set NovoSculpt apart from other clinics in the Tri-State Area and positions the clinic as a trailblazer in the aesthetic industry. Led by Expertise: Roberto Magana and a Skilled Team NovoSculpt's success is driven by the vision and leadership of its founder and CEO, Roberto Magana, MBA. With over 15 years of experience in business strategy and leadership, Roberto's guidance has been pivotal in shaping the clinic's operations and ensuring the highest standards of care. Under his leadership, NovoSculpt has assembled a highly skilled team of medical professionals, including elite plastic surgeons and experienced staff, all of whom are dedicated to delivering exceptional results for every patient. Roberto's commitment to operational excellence and patient satisfaction has been integral to the clinic's rapid growth and its recognition as the top body contouring clinic in the region. The clinic's collaboration with top-tier medical personnel ensures that each patient receives comprehensive care, with personalized treatment plans designed to meet their unique goals. Building Trust with Transparent and Safe Practices NovoSculpt's reputation is built on trust, transparency, and an unwavering focus on safety. The clinic operates within a QuadA-certified surgical suite, ensuring that every procedure is conducted in a safe and controlled environment. This certification is a reflection of the clinic's commitment to adhering to the highest medical and safety standards, providing clients with peace of mind throughout their body sculpting journey. By prioritizing patient safety and comfort, NovoSculpt has earned a loyal clientele who often return to enhance additional areas or recommend the clinic to others—confident in its ability to deliver authentic, natural-looking results in a single session. The clinic's client-first approach has fostered strong, lasting relationships with patients, many of whom experience meaningful boosts in confidence and overall well-being. Patient Satisfaction and Proven Results NovoSculpt's minimally invasive approach consistently results in high patient satisfaction, with many clients experiencing impressive, natural-looking results after just one session. The clinic's innovative fat removal procedure has become the preferred choice for those seeking to reshape their bodies without undergoing more invasive surgical procedures. In addition to fat removal, NovoSculpt offers a range of aesthetic treatments, including skin tightening with NovoTight™ and fat transfer for sculpted curves. These services are customized to each patient's specific needs, ensuring that every treatment plan aligns with their personal aesthetic vision. This personalized approach has contributed to NovoSculpt's reputation for excellence and its status as the top body contouring clinic in the Tri-State Area. A Vision of Innovation and Care NovoSculpt's success story is one of innovation, care, and patient-centric solutions. Founded by Roberto Magana, the clinic was created with the goal of offering a minimally invasive, highly effective approach to body contouring. Roberto's vision has led to the development of a clinic that fills the gaps in the market for minimally invasive, customized body sculpting treatments that deliver lasting results. As the clinic continues to innovate and grow, NovoSculpt's commitment to patient satisfaction and exceptional care remains at the forefront. The clinic's ability to adapt to changing industry trends while maintaining its focus on personalized, safe, and effective treatments has allowed it to remain a leader in the body contouring field. Celebrating Success: The 2025 Recognition NovoSculpt's recognition as the Best Body Contouring Clinic in the Tri-State Area for 2025 is a monumental achievement that celebrates the clinic's leadership, innovation, and dedication to its patients. This award reaffirms NovoSculpt's position as a disruptor in the body contouring industry, offering cutting-edge treatments that prioritize both safety and transformative results. As the clinic looks toward the future, it remains committed to setting the standard for excellence in aesthetic medicine. With a growing reputation for delivering remarkable body sculpting results, NovoSculpt continues to reshape the way individuals approach body contouring and aesthetic care. About NovoSculpt NovoSculpt is a leading body contouring clinic based in Greenwich, Connecticut, specializing in minimally invasive targeted fat removal, precision skin tightening, and aesthetic fat transfers—all performed to enhance body contours with immediate, visible results after a single session. No repeat treatments are necessary. Serving clients across the Tri-State Area and beyond, the clinic offers personalized body sculpting solutions tailored to each patient's goals. Founded by Roberto Magana, MBA, NovoSculpt combines cutting-edge technology, a skilled medical team, and a patient-centered approach to deliver safe, effective, and lasting results—without the need for traditional surgery. Media Contact Roberto Magana, MBA Founder & CEO, NovoSculpt Website: Email: [email protected] Instagram: @novosculptus Facebook: @NovoSculpt TikTok: @novosculptus LinkedIn: NovoSculpt Contact Info: Name: Roberto Magana Email: Send Email Organization: NovoSculpt Website: Release ID: 89162338 If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
Yahoo
12-06-2025
- Business
- Yahoo
Moon Surgical Discusses Maestro at NVIDIA GTC Paris, Celebrating 1,300+ Procedures in the Past Year and the Power of Physical AI
PARIS and SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Moon Surgical, the French-American leader in Physical AI for the operating room, today announced its participation at NVIDIA GTC Paris during VivaTech2025. In collaboration with NVIDIA, Moon Surgical is highlighting the Maestro System as a pioneering example of Physical AI in action—empowering surgical teams across the globe. As of today, the Maestro System has supported over 1,500 procedures worldwide, with more than 1,300 of those performed in the past year alone. With the integration of Physical AI—merging perceptive robotics and real-time computing—Maestro has proven its adaptability across 60 different minimally invasive procedures and its growing role in high-volume outpatient care. Physical AI is the integration of perceptive hardware with powerful local computing, enabling software-defined systems to understand and interact with the physical world in real time. From system deployment to procedural subtasks, physical AI combines the forces of robotic devices and agentic AI, it is the infrastructure layer to the operating room. Maestro uses ambient sensing, and robotics powered by NVIDIA Holoscan and NVIDIA IGX technologies to bring this type of capability to the clinical edge — empowering surgical teams to deliver consistent, efficient care. Anne Osdoit, CEO of Moon Surgical, will present a session titled "Reimagining Surgical Robotics as Physical AI Agents for Global Reach" at GTC Paris, spotlighting how generative Physical AI is redefining the role of surgical robotics through simulation and human collaboration. Maestro is designed to enhance—not replace—human expertise, acting as an extension of the surgical team to facilitate coordination, communication, and refined technique during minimally invasive surgery. About Moon Surgical (AI / MIS focused)Moon Surgical is transforming the operating room with Physical AI, seamlessly integrating intelligence and robotics to elevate the capabilities of surgical teams. The Maestro System represents a new category of minimally invasive surgery—expanding the scale at which robotics are delivered into the operating rooms. Instinctive, collaborative, and cost-effective, Maestro empowers teams to deliver exceptional care with greater adaptability and control. Moon Surgical. Inspiring and Innovating the Art of Surgery. For investor and media inquiries, please email us at info@ Check us out at or follow us on LinkedIn. View original content to download multimedia: SOURCE Moon Surgical
Yahoo
10-06-2025
- Business
- Yahoo
Europe Spinal Navigation Market Report 2025: Equipment-as-a-Service Models Gain Traction as Hospitals Seek Cost-Effective Navigation Solutions
The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption. European Spinal Navigation Market Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Europe Spinal Navigation Market: Analysis and Forecast, 2023-2032" report has been added to Europe spinal navigation market was valued at $192.1 million in 2023 and is expected to reach $754.7 million by 2032, registering a CAGR of 16.42% during the forecast period 2023-2032. The market for spinal navigation in Europe includes cutting-edge guidance systems that help surgeons perform spine surgeries by showing the patient's anatomy in three dimensions in real time. These technologies, which include augmented reality headsets, AI-driven software overlays, optical and electromagnetic trackers, and more, are designed to improve surgical accuracy, lower intraoperative risks, and speed up recovery. The need for minimally invasive procedures has increased recently because to the growing prevalence of degenerative disc disease, spinal stenosis, and traumatic injuries in an ageing European population, making navigation technology essential tools for modern practice. With the use of advanced instruments that increase procedural accuracy, enhance patient safety, and produce better clinical results, the spinal navigation market in Europe is quickly changing the face of spine surgery. However, the high initial investment and continuing maintenance costs of these platforms continue to limit their widespread adoption throughout EU healthcare systems. Expanding access and providing patients across Europe with high-quality care will depend on overcoming these financial obstacles through creative funding models, advantageous reimbursement schemes, and cooperative procurement tactics. Integrated operating-room suites, where navigation systems seamlessly connect with robotic arms and imaging modalities (CT, fluoroscopy, intraoperative MRI) to provide multifunctional capabilities, are becoming more and more common in hospitals and ambulatory surgical centres. In order to overcome financial limitations, equipment-as-a-service and shared-service procurement models have surfaced, allowing smaller institutions to access state-of-the-art platforms without having to make significant capital expenditures. However, due to a variety of national legislation, complicated payment procedures, and the requirement for substantial staff training, adoption is still are concentrating on enhancing tracking precision, optimising user interfaces, and incorporating predictive analytics to foresee intraoperative difficulties in the future. To broaden reimbursement systems and harmonise standards, OEMs, payers, and healthcare providers must cooperate together. The market for spinal navigation in Europe is expected to increase steadily as clinical proof of better patient outcomes and cost-effectiveness mounts, spurring advancements in spine surgery and wider surgical navigation applications. Europe Spinal Navigation Market Trends, Drivers and Challenges: Trends Increasing integration of AI-driven algorithms and augmented/virtual reality overlays to provide real-time, 3D intraoperative guidance. Convergence of robotic-assisted systems with traditional optical and electromagnetic navigation platforms, creating multifunctional operating suites. Growth of shared-service procurement and equipment-as-a-service models, enabling hospitals and surgical centres to spread capital expenditures and access the latest systems without large upfront investments. Drivers Europe's aging population and rising incidence of degenerative spinal conditions are driving demand for precise, minimally invasive procedures that reduce hospital stays and complication rates. Emphasis on patient safety and outcome-based reimbursement is accelerating adoption of navigation tools that minimise radiation exposure and improve surgical accuracy. Continuous technological advances - in tracking accuracy, user interfaces and data analytics - are enhancing surgeon confidence and expanding clinical applications beyond routine procedures. Challenges High initial purchase prices and ongoing maintenance expenses strain healthcare budgets, especially under tight reimbursement caps across different EU member states. Diverse, country-specific regulatory requirements and inconsistent reimbursement frameworks impede pan-European rollout and create market entry complexities. Integrating advanced navigation systems into existing OR infrastructures requires significant workflow adjustments and dedicated staff training, slowing adoption in smaller hospitals and outpatient centres. Key Attributes: Report Attribute Details No. of Pages 87 Forecast Period 2023 - 2032 Estimated Market Value (USD) in 2023 $192.1 Million Forecasted Market Value (USD) by 2032 $754.7 Million Compound Annual Growth Rate 16.4% Regions Covered Europe Key Topics Covered: 1 Executive Summary2 Market Definition and Scope3 Research Methodology4 Regulatory Scenario and Device Classification4.1 Regulatory Scenario in the EU4.2 Regulatory Scenario in the U.K.5 Reimbursement Scenario5.1 Reimbursement Scenario in the U.K.6 Procedure Volume of Spinal Conditions7 Spinal Navigation Market (by Region)7.1 Europe Spinal Navigation Market (by End User)7.2 Europe Spinal Navigation Market, Installed Base (by End User)7.3 U.K. Spinal Navigation Market7.4 Germany Spinal Navigation Market7.5 France Spinal Navigation Market7.6 Italy Spinal Navigation Market7.7 Spain Spinal Navigation Market7.8 Austria Spinal Navigation Market7.9 Rest-of-Europe Spinal Navigation Market8 Hospital Profiles9 Company Profiles9.1 ERGOSURG GmbH9.2 Brainlab AG9.3 Siemens Healthineers AG9.4 B. Braun9.5 Joimax GmbH9.6 RIWOspine GmbHCompanies Featured ERGOSURG GmbH Brainlab AG Siemens Healthineers AG B. Braun Joimax GmbH RIWOspine GmbH For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment European Spinal Navigation Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Khaleej Times
30-05-2025
- Health
- Khaleej Times
Redefining surgical excellence in the Northern Emirates – Thumbay University Hospital Ajman
Thumbay University Hospital in Ajman has rapidly established itself as the foremost destination for advanced surgical care in the Northern Emirates. As one of the region's largest academic hospitals, it combines cutting-edge medical technology, internationally trained surgeons, and a patient-first approach—making it the most trusted hub for a wide range of surgical specialties. What sets Thumbay University Hospital apart is not only the breadth of services offered, but also its commitment to minimally invasive techniques, faster recovery, and better patient outcomes. The hospital has become synonymous with innovation and surgical precision, offering a level of care that rivals global centers of excellence. One of the recent cases highlighting the hospital's capabilities involved a 60-year-old woman suffering from postmenopausal bleeding and significant pelvic discomfort. She was diagnosed with a large fibroid uterus—equivalent in size to a five-month pregnancy. Multiple medical institutions advised her to undergo an open hysterectomy, a more invasive procedure. However, due to her high BMI, the patient and her family were apprehensive about the risks involved. At Thumbay University Hospital, Dr Amal Hassan Abddelaziz, consultant and her team successfully performed a total laparoscopic hysterectomy with bilateral salpingo-oophorectomy, enabling the patient to be discharged the very next day and return to her daily routine shortly after—a testament to the hospital's minimally invasive expertise. In yet another milestone achievement, Thumbay University Hospital became the first in the Northern Emirates to successfully complete a body contouring procedure using advanced VASER ultrasonic liposuction combined with J-Plasma skin tightening technology. This groundbreaking surgery, performed by renowned plastic surgeon Dr Faisal Ameer, consultant at the hospital's Thumbay Institute of Aesthetics (TIA), showcases the hospital's leadership in blending aesthetic precision with medical innovation. It represents a new era of cosmetic surgery in the region, marrying technology and patient care to achieve exceptional results. Reflecting on these advancements, Akbar Moideen Thumbay, vice-president and board member of Thumbay Group, stated: "Thumbay University Hospital is committed to being the region's benchmark in surgical care—bringing together the best of technology, talent, and compassion. These pioneering cases are a testament to our promise of safe, innovative, and patient-friendly surgeries in the UAE." With every successful surgery, Thumbay University Hospital reinforces its position as a center of excellence—not just in the Northern Emirates but across the UAE. Patients seeking high-quality, expert-led surgical care are increasingly turning to this world-class facility that continues to deliver medical breakthroughs with a human touch.
